Literature DB >> 1499905

Characterization of spontaneous and ethanol-induced gastric damage in cirrhotic rats.

P L Beck1, S S Lee, G W McKnight, J L Wallace.   

Abstract

Cirrhosis was induced in Sprague-Dawley rats via ligation of the common bile duct. Changes in gastric blood flow and mucosal architecture were examined. Using an ex vivo gastric chamber preparation, the susceptibility of the cirrhotic gastric mucosa to injury by 20% ethanol was also examined. The gastric mucosa of cirrhotic animals was abnormal, even before ethanol administration. The macroscopically visible damage in these animals ranged from superficial hyperemia to epithelial sloughing. These gastric lesions were similar in appearance to the gastropathy described in cirrhotic patients, including "cherry-red spots" and areas of generalized erythema. Cirrhotic rats had a lower resting gastric transmucosal potential difference than control rats, and their gastric mucosa was also significantly more susceptible to damage by topical ethanol application. Ethanol administration caused a significant increase in gastric blood flow in control rats, whereas it significantly decreased gastric blood flow in cirrhotic rats. This lack of a reactive hyperemic response in cirrhotic rats may be responsible for the increased susceptibility of the gastric mucosa to ethanol-induced damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499905     DOI: 10.1016/0016-5085(92)90042-w

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  Mechanisms of gastroprotection by transdermal nitroglycerin in the rat.

Authors:  S Calatayud; M J Sanz; A Canet; R Bello; F D de Rojas; J V Esplugues
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Gastric mucosal resistance to acute injury in experimental portal hypertension.

Authors:  S Calatayud; M C Ramírez; M J Sanz; L Moreno; C Hernández; J Bosch; J M Piqué; J V Esplugues
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Endothelin and neonatal capsaicin regulate gastric resistance to injury in BDL rats.

Authors:  Paula Rs Câmara; Gerson Jn Ferraz; Licio A Velloso; José Murilo R Zeitune; Fernando Ab Suassuna; Jose Geraldo P Ferraz
Journal:  World J Gastrointest Pathophysiol       Date:  2012-08-15

6.  Gastropathy and defense mechanisms in common bile duct ligated portal hypertensive rats.

Authors:  S Kaur; U Kaur; C Tandon; V Dhawan; N K Ganguly; S Majumdar
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

7.  Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients.

Authors:  Jean Auroux; Dominique Lamarque; Françoise Roudot-Thoraval; Lionel Deforges; Marie Thérèse Chaumette; Jean Philippe Richardet; Jean Charles Delchier
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 8.  Portal hypertensive gastropathy and gastric antral vascular ectasia.

Authors:  Hitendra Garg; Subhash Gupta; A C Anand; S L Broor
Journal:  Indian J Gastroenterol       Date:  2015-11-13

Review 9.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03

10.  Effect of sodium butyrate on gastric ulcer aggravation and hepatic injury inflicted by bile duct ligation in rats.

Authors:  Neveen A Elnozahi; Esraa A Said; Azza E Bistawroos; Rania G Aly
Journal:  Saudi Pharm J       Date:  2020-04-25       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.